Spectral AI Announces Q4 and Full Year 2024 Financial Results Conference Call

Spectral AI Schedules Financial Results Conference Call

Spectral AI (NASDAQ: MDAI), a Dallas-based predictive AI company specializing in medical diagnostics, has announced that it will release its financial results for the fourth quarter and full year of 2024 on Wednesday, March 27, 2025, after the stock market closes 1

1

2

2

. The company will follow this with a conference call at 5:00 pm Eastern Time to discuss the results with investors and analysts.

About Spectral AI and DeepView® System

Spectral AI is at the forefront of revolutionizing wound care management with its AI-driven DeepView® System. This innovative technology, which received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) in 2018, utilizes multi-spectral imaging and AI algorithms to predict burn healing potential 1

1

2

2

.

The DeepView® System is designed to provide clinicians with an objective and immediate assessment of a wound's healing potential before treatment or medical intervention. This predictive diagnostic tool aims to significantly improve the current standard of care by offering faster and more accurate treatment insights, potentially leading to better patient outcomes and reduced healthcare costs 1

1

2

2

.

Investor Participation and Webcast Details

Investors interested in participating in the live call can dial:

• 844-481-3008 for U.S. callers
• 412-317-1892 for international callers 1

  1

Additionally, a simultaneous webcast of the call will be accessible online from the Events & Presentations section of the Investor Relations page on Spectral AI's website 1

1

2

2

.

Forward-Looking Statements and Investor Caution

As with many companies in the medical technology sector, Spectral AI has included forward-looking statements in its announcement. These statements, protected under the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995, relate to the company's strategy, plans, objectives, and financial outlook 1

1

2

2

.

However, investors are cautioned that these forward-looking statements are not guarantees of future performance. The company acknowledges that there are known and unknown risks, uncertainties, and other important factors that could cause actual results to differ materially from those projected in the forward-looking statements 1

1

2

2

.

Potential Impact on AI in Healthcare

Spectral AI's work with the DeepView® System represents a significant application of artificial intelligence in healthcare, particularly in wound care and burn treatment. The company's focus on using AI for faster and more accurate treatment decisions could potentially set new standards in medical diagnostics and patient care strategies 1

1

2

2

.

As Spectral AI prepares to share its financial results, the medical and tech communities will be watching closely to gauge the progress and potential of AI-driven diagnostic tools in clinical settings. The upcoming financial report and conference call may provide valuable insights into the commercial viability and future prospects of AI applications in healthcare.